Rheumatology

Publications

Avar-Aydın, PÖ; Brunner, HI. Revisiting Childhood-Onset Systemic Lupus Erythematosus. Turkish Archives of Pediatrics. 2024; 59:336-344.

Avar-Aydin, PO; Ting, TV; Vega-Fernandez, P. Imaging in Juvenile Idiopathic Arthritis. Rheumatic Disease Clinics of North America. 2024; 50:623-640.

Banschbach, KM; Singleton, J; Wang, X; Vora, SS; Harris, JG; Lytch, A; Pan, N; Klauss, J; Fair, D; Hammelev, E; Gilbert, M; Kreese, C; Machado, A; Tarczy-Hornoch, P; Morgan, EM. Assessing disparities through missing race and ethnicity data: results from a juvenile arthritis registry. Frontiers in Pediatrics. 2024; 12:1430981.

Barter, KM; Fuchs, C; Graham, TB; Pagano, LM; Vater, M. Anti-NMDAR Encephalitis Clinical Practice Guideline: Improving Time to Diagnosis, Treatment, and Hospital Length of Stay. Neurology: Clinical Practice. 2024; 14:e200218.

Brunner, HI; Akikusa, JD; Al-Abadi, E; Bohnsack, JF; Boteanu, AL; Chedeville, G; Cuttica, R; De La Pena, W; Jung, L; Kasapcopur, O; Liu, S; Martini, A; Lovell, DJ; Ruperto, N. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study. Annals of the Rheumatic Diseases. 2024; 83:1561-1571.

Brunner, HI; Pacheco-Tena, C; Louw, I; Vega-Cornejo, G; Alexeeva, E; Appenzeller, S; Chasnyk, V; Griffin, T; Suarez, CN; Knupp-Oliveira, S; Spindler, A; Terreri, MT; Viola, DO; Xavier, RM. Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study. The Journal of rheumatology. 2024; 51:1125-1134.

Brunner, HI; Ruperto, N; Ramanan, AV; Horneff, G; Minden, K; Calvo Penades, I; Alexeeva, E; Cleary, G; Stern, SM; Kone-Paut, I; Wagner-Weiner, L; Stern, S; Zeft, A; Dare, J. Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis. Rheumatology. 2024; 63:2535-2546.

Brunner, HI; Schulert, GS; Sproles, A; Thornton, S; Cornejo, GV; Antón, J; Cuttica, R; Henrickson, M; Foeldvari, I; Kingsbury, DJ; Lovell, DJ; Martini, A; Ruperto, N; Grom, AA. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis. Arthritis Research and Therapy. 2024; 26:125.

Chang, MH; Barbar-Smiley, F; Akoghlanian, S; Drew, J; Angeles-Han, ST; Quinlan-Waters, M; Bohnsack, JF; Cooper, AM; Edelheit, B; Twachtman-Bassett, J; Stern, S; Sterba Rakovchik, Y; Stephens, A; Steigerwald, K. Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research. Pediatric Rheumatology Online Journal. 2024; 22:88.

Cody, E; Brunner, HI. Renal disease in pediatric rheumatology. Current Opinion in Rheumatology. 2024; 36:322-327.

Connelly, K; Koelmeyer, R; Ayton, D; May, J; Gregory, K; Eades, L; Barallon, R; Kandane-Rathnayake, R; Golder, V; Anzum, A; Furie, RA; Van Vollenhoven, RF; Banerjee, S; Morand, E. AB0982 DOMAINS FOR INCLUSION IN A NOVEL TREATMENT RESPONSE MEASURE FOR SYSTEMIC LUPUS ERYTHEMATOSUS (TRM-SLE): RESULTS OF A MODIFIED DELPHI STUDY. Annals of the Rheumatic Diseases. 2024; 83:1805-1807.

Correia Marques, M; Ombrello, MJ; Schulert, GS. New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis. Expert Review of Clinical Immunology. 2024; 20:1053-1064.

Correia Marques, M; Rubin, D; Shuldiner, EG; Datta, M; Schmitz, E; Gutierrez Cruz, G; Patt, A; Bennett, E; Grom, A; Foell, D; Woo, P; Yeung, RS M; Zeft, AS; Zeggini, E. Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis. Arthritis and Rheumatology. 2024; 76:1566-1572.

Correll, CK; Klein-Gitelman, MS; Henrickson, M; Battafarano, DF; Orr, CJ; Leonard, MB; Mehta, JJ. Child Health Needs and the Pediatric Rheumatology Workforce: 2020-2040. Pediatrics. 2024; 153:e2023063678R.

de Benedetti, F; Grom, AA; Brunner, H. The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study. Pediatric Rheumatology Online Journal. 2024; 21:150.

Ebert, JJ; Maccora, I; Sapp, CC; Nguyen, T; Sisk, RA; Srivastava, SK; Angeles-Han, ST; Sood, AB. Ultrawidefield Fluorescein Angiography and OCT Findings in Children and Young Adults with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy. Ophthalmology Retina. 2024; 8:1107-1112.

Erkens, RG A; Calis, JJ A; Verwoerd, A; De Roock, S; Ter Haar, NM; Den Engelsman, G; Van der Veken, LT; Ernst, RF; Van Deutekom, HW M; Pickering, A; Schulert, GS; Grom, AA; Van Loosdregt, J; Vastert, SJ. Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN Variants. Arthritis and Rheumatology. 2024; 76:119-129.

Fautrel, B; Mitrovic, S; De Matteis, A; Bindoli, S; Antón, J; Belot, A; Bracaglia, C; Constantin, T; Dagna, L; Di Bartolo, A; Wilhelmer, T; Wouters, C; Carmona, L; De Benedetti, F. EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease. Annals of the Rheumatic Diseases. 2024; 83:1614-1627.

Grom, AA. Genetics of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis. Advances in Experimental Medicine and Biology. 2024; 1448:121-126.

Grom, AA; Canna, SW; Abu-Arja, RF; Sinha, R; Peixoto, L; Cannizzaro, E; Chandrakasan, S; Driest, K; Marsh, R; Neven, B; Schulert, G; Silva, JM F; Wall, D; Zeilhofer, U. Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe. Pediatric Rheumatology Online Journal. 2024; 21:86.

Gulick, RM; Pau, AK; Daar, E; Evans, L; Gandhi, RT; Tebas, P; Ridzon, R; Masur, H; Lane, HC; Aberg, J; Uyeki, TM; Waghmare, AA; Wolfe, CR; Yazdany, J. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. Annals of Internal Medicine. 2024; 177:1547-1557.

Harris, JG; Bingham, CA; Vora, SS; Yildirim-Toruner, C; Batthish, M; Bullock, DR; Burnham, JM; Fair, DC; Ferraro, K; Ganguli, S; Pan, N; Shishov, M; Weiss, JE; Morgan, EM. Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network. Frontiers in Pediatrics. 2024; 12:1434074.

Huang, B; Kouril, M; Chen, C; Daraiseh, NM; Ferraro, K; Mannion, ML; Brunner, HI; Lovell, DJ; Morgan, EM. Digital health technology to support patient-centered shared decision making at point of care for juvenile idiopathic arthritis. Frontiers in Pediatrics. 2024; 12:1457538.

Huang, Y; Sompii-Montgomery, L; Patti, J; Pickering, A; Yasin, S; Do, T; Baker, E; Gao, D; Abdul-Aziz, R; Behrens, EM; Ting, T; Grom, AA; Towe, C; Schulert, GS. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Arthritis Care and Research. 2024; 76:328-339.

Jackson, CV; Banschbach, KM; Wong, SC; Menon, S. Recent Diagnosis of Lupus and Severe Hypertriglyceridemia in a 12-year-old Girl. Pediatrics in review / American Academy of Pediatrics. 2024; 45:601-605.

Kammeyer, R; Chapman, K; Furniss, A; Hsieh, E; Fuhlbrigge, R; Ogbu, EA; Boackle, S; Zell, JA; Nair, KV; Borko, TL; Cooper, JC; Bennett, JL; Piquet, AL. Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus. Lupus. 2024; 33:1116-1129.

Kammeyer, R; Chapman, K; Furniss, A; Ogbu, E; Nair, K; Borko, T; Fuhlbrigge, R; Bennett, J; Boackle, S; Hsieh, E; Zell, J; Cooper, J; Piquet, A. Blood-based Biomarkers of Neuronal and Glial Damage in Active Major Neuropsychiatric Systemic Lupus Erythematosus (P8-14.012). Neurology. 2024; 102.

Kammeyer, R; Ogbu, EA; Cooper, JC; Stolz, E; Piquet, AL; Fuhlbrigge, RC; Bennett, JL; Hutaff-Lee, C. [Formula: see text] Cognitive dysfunction in pediatric systemic lupus erythematosus: current knowledge and future directions. Child Neuropsychology. 2024; 30:818-846.

Kumar, A; Tatarian, J; Shakhnovich, V; Chevalier, RL; Sudman, M; Lovell, DJ; Thompson, SD; Becker, ML; Funk, RS. Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis. Metabolites. 2024; 14:499.

Lovell, DJ; Tzaribachev, N; Henrickson, M; Simonini, G; Griffin, TA; Alexeeva, E; Bohnsack, JF; Zeft, A; Horneff, G; Vehe, RK; Costanzo, D; Rennebohm, R; Waugaman, B; Brodus, E. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry. Rheumatology. 2024; 63:SI195-SI206.

Maccora, I; Ebert, JJ; Schulert, GS; Quinlan-Waters, M; Duell, A; Huggins, JL; Sapp, CC; Nguyen, T; Srivastava, SK; Sood, AB; Angeles-Han, ST. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation (Informa). 2024; 32:2441-2448.

Mandel, M; Elhusseiny, AM; Davidson, SL; Rockter, A; Levin, AV; Huang, LC; Cheung, CS Y; Stahl, ED; Cooper, AM; Jin, J; Utz, VM; Angeles-Han, ST; Oke, I; Nihalani, BR. Clinical outcomes in paediatric tubulointerstitial nephritis and uveitis syndrome (TINU). Eye. 2024; 38:3318-3324.

Mannion, ML; Amin, S; Balevic, S; Chang, ML; Correll, CK; Kearsley-Fleet, L; Hyrich, KL; Beukelman, T; Aamir, R; Abulaban, K; DeSantis, E; Devine, R; Dhalla, M; Dhanrajani, A. Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2024; 76:1090-1098.

Nazzar, S; Moorthy, L; Tousseau, J; Lapidus, S; Mansfield, L; Twilt, M; Schulert, G; Gutierrez, M; Angevare, S; Durrant, K; Dedeoglu, F. Effects of the COVID-19 Pandemic in Patients with Systemic Autoinflammatory Diseases. An international survey. 2024; 12.

Nigrovic, PA; de Benedetti, F; Kimura, Y; Lovell, DJ; Vastert, SJ. The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease. Pediatric Rheumatology Online Journal. 2024; 21:114.

Ogbu, EA; Brunner, HI; Eloseily, E; Aviel, YB; Nanda, K; Schmeling, H; Tory, H; Uziel, Y; Viola, DO; Wahezi, DM; Ruperto, N; Huang, B; Grom, A; Thornton, S. Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2024; 76:1723-1732.

Pandurangi, S; Malik, A; Owens, J; Valencia, CA; Miethke, AG; Marsh, R; Chiang, S; Yang, L; Hopkin, R; Kasten, J; Huggins, J; Gutierrez Sanchez, LH; Castro-Rojas, C; Alquaraish, M. Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis. Journal of Hepatology. 2024; 80:e26-e28.

Peng, J; Dönnes, P; Ardoin, SP; Schanberg, LE; Lewandowski, L; Ardoin, S; Dewitt, EM; Rabinovich, CE; Ellis, J; Mieszkalski, K; Paepke-Tollefsrud, DE; Robinson, G; Jury, EC; Ciurtin, C. Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature. Arthritis and Rheumatology. 2024; 76:455-468.

Perron, MM; Ziniel, SI; Curran, M; Bloom, JL; Vega-Fernandez, P; Benham, H; Torralba, K; De Ranieri, D; Lin, C. Needs Assessment of Musculoskeletal Ultrasound Training in North American Pediatric Rheumatology Fellowship Programs. Arthritis Care and Research. 2024; 76:1116-1120.

Sagcal-Gironella, AC P; Merritt, A; Mizuno, T; Dharnidharka, VR; McDonald, J; DeGuzman, M; Wahezi, D; Goilav, B; Onel, K; Kim, S; Hersh, A; Huang, B; Devarajan, P; Brunner, H. Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study). Journal of Clinical Trials. 2024; 14:563.

Saper, VE; Tian, L; Verstegen, RH J; Conrad, CK; Cidon, M; Hopper, RK; Kuo, CS; Osoegawa, K; Baszis, K; Bingham, CA; Ambler, W; Amoruso, M; Angeles-Han, S; Ardoin, S. Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses. The Journal of Allergy and Clinical Immunology: in Practice. 2024; 12:2996-3013.e7.

Schulert, G; Vastert, SJ; Grom, AA. The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA. Pediatric Rheumatology Online Journal. 2024; 21:87.

Schulert, GS; Zhang, K. Genetics of Acquired Cytokine Storm Syndromes : Secondary HLH Genetics. Advances in Experimental Medicine and Biology. 2024; 1448:103-119.

Sinha, R; De Benedetti, F; Grom, AA; participants listed below, . Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13-14, 2022. Pediatric Rheumatology Online Journal. 2024; 21:91.

Vater, M; Davis, A; Jaser, S. Evaluation of health literacy and its association with medication adherence and quality of life in childhood-onset systemic lupus erythematosus. Lupus. 2024; 33:1004-1011.

Vega-Fernandez, P; Rogers, K; Avar-Aydin, PO; Quinlan-Waters, M; Huggins, J; Brunner, HI; Lovell, DJ; Altaye, M; Cassedy, A; Meyers, AB; Ting, TV. Validation of the ankle-specific pediatric arthritis ultrasound scoring system in children with juvenile idiopathic arthritis. Seminars in Arthritis and Rheumatism. 2024; 69:152545.

Vega-Fernandez, P; Rogers, K; Sproles, A; Thornton, S; Huggins, J; Lovell, DJ; Cassedy, A; Meyers, AB; Ting, TV. Diagnostic Accuracy Study of the Pediatric-Specific Ultrasound Scoring System for the Knee Joint in Children With Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2024; 76:251-258.

Weiss, PF; Brandon, TG; Aggarwal, A; Burgos-Vargas, R; Colbert, RA; Horneff, G; Laxer, RM; Minden, K; Ravelli, A; Ruperto, N; Ozen, S; Naden, R; Hendry, AM; Joos, R. Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis. Arthritis and Rheumatology. 2024; 76:1797-1808.